The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded IDT Biologika, a globally integrated manufacturer of vaccines and biopharmaceuticals, a 10-year Indefinite Quantity, Indefinite Delivery (IDIQ) contract to provide process development, manufacturing, and characterization of vaccine and biologic products for infectious diseases. The total funding could…